🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Drug Gaining Popularity Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining promotional offers.

Active Trade on Social Networks

Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and assertions of next-day British shipping. Sellers market the substance there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed medication in the UK is worrisome and could lead to users injecting products of uncertain source.

Some experts stated the demand for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate pharmaceutical, marketing, and customer laws, potentially leading to penalties, legal action or prison.

Service Response and Material Removal

Based on the social media company, the platform has taken down violative material and banned related keywords and query recommendations. The organization said it was dedicated to maintaining the platform safe and investing in strengthening enforcement strategies.

Online Trading Activities

Research also found groups with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up channels with numerous of members, filled with images of weight loss, positive testimonials and step-by-step instructions for preparing or administering at home.

Within minutes of entering one group, a vendor shared WhatsApp details, where the majority of purchases occur. The seller provided an guidebook and promised delivery within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Information and Costs

Within these groups, posts display black plastic packages with postal service stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram stated it actively moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting materials they can’t verify. Although the science behind this drug is sound, these digital versions may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, patients are using online platforms. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has previously seen individuals harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to potentially serious health risks”.